Literature DB >> 12527037

Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion.

Thierry Lamireau1, Monica Zoltowska, Emile Levy, Ibrahim Yousef, Jean Rosenbaum, Beatriz Tuchweber, Alexis Desmoulière.   

Abstract

Hydrophobic bile acids, which are known to be cytotoxic for hepatocytes, are retained in high amount in the liver during cholestasis. Thus, we have investigated the effects of bile acids with various hydrophobicities on biliary epithelial cells. Biliary epithelial cells were cultured in the presence of tauroursodeoxycholate (TUDC), taurocholate (TC), taurodeoxycholate (TDC), taurochenodeoxycholate (TCDC), or taurolithocholate (TLC). Cell proliferation, viability, apoptosis and secretion of monocyte chemotactic protein-1 (MCP-1) and of interleukin-6 (IL-6) were studied. Cell proliferation was increased by TDC, and markedly decreased by TLC in a dose dependent manner (50-500 microM). Cell viability was significantly decreased by TLC and TCDC at 500 microM. TLC, TDC and TCDC induced apoptosis at high concentrations. The secretion of MCP-1 and IL-6 was markedly stimulated by TC. TUDC had no significant effect on any parameter. These findings demonstrate that hydrophobic bile acids were cytotoxic and induced apoptosis of biliary epithelial cells. Furthermore, TC, a major biliary acid in human bile, stimulated secretion of cytokines involved in the inflammatory and fibrotic processes occurring during cholestatic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527037     DOI: 10.1016/s0024-3205(02)02408-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  28 in total

Review 1.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

2.  Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations.

Authors:  Christelle Guyot; Chantal Combe; Haude Clouzeau-Girard; Valérie Moronvalle-Halley; Alexis Desmoulière
Journal:  Virchows Arch       Date:  2007-03-13       Impact factor: 4.064

Review 3.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 5.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

6.  Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.

Authors:  Alexander G Miethke; Wujuan Zhang; Julia Simmons; Amy E Taylor; Tiffany Shi; Shiva Kumar Shanmukhappa; Rebekah Karns; Shana White; Anil G Jegga; Celine S Lages; Stephenson Nkinin; Bradley T Keller; Kenneth D R Setchell
Journal:  Hepatology       Date:  2015-08-21       Impact factor: 17.425

Review 7.  Factors inhibiting intestinal calcium absorption: hormones and luminal factors that prevent excessive calcium uptake.

Authors:  Kannikar Wongdee; Mayuree Rodrat; Jarinthorn Teerapornpuntakit; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2019-06-20       Impact factor: 2.781

8.  Regulation and function of trefoil factor family 3 expression in the biliary tree.

Authors:  Isao Nozaki; John G Lunz; Susan Specht; Jong-In Park; Andrew S Giraud; Noriko Murase; Anthony J Demetris
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.

Authors:  Yan-Li Hao; Zhao-Lian Bian; Lin-Ling Ju; Yuan Liu; Gang Qin
Journal:  Dig Dis Sci       Date:  2019-08-03       Impact factor: 3.199

10.  Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.

Authors:  Junquan Xu; Gene Lee; Haimei Wang; John M Vierling; Jacquelyn J Maher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-05-06       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.